Susquehanna International Group’s 9 Meters Biopharma NMTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-17,089
Closed -$11.5K 13462
2023
Q2
$11.5K Buy
+17,089
New +$15.1K ﹤0.01% 11741
2022
Q4
Sell
-1,430
Closed -$3.26K 14212
2022
Q3
$6K Sell
1,430
-7,403
-84% -$36.7K ﹤0.01% 12873
2022
Q2
$46K Buy
8,833
+2,525
+40% +$23.8K ﹤0.01% 12032
2022
Q1
$76K Sell
6,308
-7,820
-55% -$107K ﹤0.01% 12086
2021
Q4
$276K Buy
14,128
+12,136
+609% +$271K ﹤0.01% 10686
2021
Q3
$52K Sell
1,992
-21,175
-91% -$499K ﹤0.01% 12336
2021
Q2
$510K Sell
23,167
-3,403
-13% -$83.5K ﹤0.01% 9547
2021
Q1
$622K Buy
+26,570
New +$816K ﹤0.01% 8966
2018
Q2
Sell
-3,524
Closed -$1.3M 10653
2018
Q1
$1.93M Buy
+3,524
New +$686K ﹤0.01% 3986
2017
Q1
Sell
-64
Closed -$22K 10253
2016
Q4
$22K Buy
+64
New +$18.6K ﹤0.01% 9422

Other funds holding NMTR

Susquehanna International Group's NMTR Position: Q3 2023 in Review

Susquehanna International Group sold out of 9 Meters Biopharma (NMTR) in Q3 2023, closing a stake of 17,089 shares — an estimated $11.5K sold.

Susquehanna International Group first reported a position in NMTR in Q4 2016 and held it in 10 quarters. The position peaked at $1.93M in Q1 2018. 6 funds tracked by Wall St. Rank hold NMTR as of Q3 2023.

  • Susquehanna International Group reported no remaining 9 Meters Biopharma position as of Q3 2023 after selling out during the quarter.
  • Susquehanna International Group sold 17,089 9 Meters Biopharma shares in Q3 2023, an estimated $11.5K.
  • Susquehanna International Group first reported a position in 9 Meters Biopharma in Q4 2016 and held it in 10 quarters.
  • Susquehanna International Group's 9 Meters Biopharma position peaked at $1.93M in Q1 2018.
  • 6 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2023.

Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.